...
首页> 外文期刊>Journal of clinical laboratory analysis. >Development and validation of a predictive model for the prognosis in aneurysmal subarachnoid hemorrhage
【24h】

Development and validation of a predictive model for the prognosis in aneurysmal subarachnoid hemorrhage

机译:动脉瘤性蛛网膜下腔预测预测模型的开发与验证

获取原文

摘要

Background This study was to conduct a predictive model for the prognosis of aneurysmal subarachnoid hemorrhage (aSAH) and validate the clinical data. Methods A total of 235 aSAH patients were enrolled in this study, dividing into the favorable or poor prognosis groups based on Modified Rankin Scale (mRS) at 3?months postoperatively. Multivariate analysis was assessed using binary Logistic regression and Fisher discriminant analysis. The receiver operating characteristic (ROC) curve was used to determine the cut‐off value. Results Our findings showed that the high Glasgow Coma Scale (GCS) score 24‐hour after surgery reduced the risk of poor prognosis, and the surgical clipping and elevated neutrophil‐lymphocyte ratio (NLR) increased the risk of poor prognosis. The discriminant function was V?=?0.881?×?GCS score???0.523?×?NLR???0.422?×?therapeutic approach, and V?=??0.689 served as a cut‐off value. When V?≥??0.689, the good prognosis was considered among these patients with aSAH. The correctness for predicting the prognostic outcomes by self‐validation was 85.11%. Conclusion This predictive model established by a discriminant analysis is a useful tool for predicting the prognostic outcomes of aSAH patients, which may help clinicians identify patients at high risk for poor prognosis and optimize treatment after surgery.
机译:背景技术本研究是对动脉瘤性蛛网膜下腔(ASAH)预测进行预测模型,并验证临床资料。方法共于本研究招生了235例ASAH患者,基于修饰的Rankin规模(MRS)在术后3个月,除以良好或差的预后组。使用二元逻辑回归和Fisher判别分析评估多变量分析。接收器操作特性(ROC)曲线用于确定截止值。结果我们的研究结果表明,手术后24小时Glasgow Coma Scale(GCS)得分,降低预后差的风险,外科剪裁和升高的中性粒细胞淋巴细胞比率(NLR)增加了预后差的风险。判别函数是v?=?0.881?×gcs得分??? 0.523?×nlr ??? 0.422?×x?治疗方法,v?= 0.689用作截止值。当v?≥?? 0.689时,这些患者中考虑了良好的预后。通过自我验证预测预后结果的正确性为85.11%。结论该判别分析建立的这种预测模型是预测asah患者的预后结果的有用工具,这可能有助于临床医生判断高风险患者的预后和手术后优化治疗。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号